Page last updated: 2024-08-24

nelfinavir and Salivary Gland Neoplasms

nelfinavir has been researched along with Salivary Gland Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, CM; Buatti, JM; Hoffman, HT; Hoover, AC; Milhem, MM; Smith, BJ; Sun, W	1

Trials

1 trial(s) available for nelfinavir and Salivary Gland Neoplasms

Article	Year
Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial. Head & neck, 2015, Volume: 37, Issue:5 Topics: Adult; Age Factors; Aged; Carcinoma, Adenoid Cystic; Cause of Death; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hospitals, University; Humans; Iowa; Male; Maximum Tolerated Dose; Middle Aged; Nelfinavir; Prospective Studies; Risk Assessment; Salivary Gland Neoplasms; Sex Factors; Survival Rate; Treatment Outcome; United States	2015

Article

Year

Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial.

Head & neck, 2015, Volume: 37, Issue:5

Topics: Adult; Age Factors; Aged; Carcinoma, Adenoid Cystic; Cause of Death; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hospitals, University; Humans; Iowa; Male; Maximum Tolerated Dose; Middle Aged; Nelfinavir; Prospective Studies; Risk Assessment; Salivary Gland Neoplasms; Sex Factors; Survival Rate; Treatment Outcome; United States

2015